{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:16:55Z","timestamp":1776248215761,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130899","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T14:37:05Z","timestamp":1435329425000},"page":"e0130899","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C"],"prefix":"10.1371","volume":"10","author":[{"given":"Krzysztof","family":"Domagalski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Paw\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Kozielewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Dybowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Tretyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar","family":"Halota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1440-1746.2010.06550.x","article-title":"Hepatitis C virus: How genetic variability affects pathobiology of disease","volume":"26","author":"K Chayama","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","article-title":"Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin","volume":"30","author":"T Asselah","year":"2010","journal-title":"Liver Int"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep.22543","article-title":"Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors","volume":"48","author":"H Shirakawa","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"e15895","DOI":"10.5812\/hepatmon.15895","article-title":"Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis","volume":"14","author":"SH Aalaei-Andabili","year":"2014","journal-title":"Hepat Mon"},{"issue":"7262","key":"ref5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1741-7015-11-6","article-title":"Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C","volume":"11","author":"MA Jimenez-Sousa","year":"2013","journal-title":"BMC Med"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"A Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Y Tanaka","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"V Suppiah","year":"2009","journal-title":"Nat Genet"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.6","article-title":"Interferons and viral infections","volume":"35","author":"V Fensterl","year":"2009","journal-title":"Biofactors"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"T Asselah","year":"2008","journal-title":"Gut"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"L Chen","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jhep.2010.09.019","article-title":"IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy","volume":"54","author":"H Abe","year":"2011","journal-title":"J Hepatol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"M Honda","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"19799","DOI":"10.1371\/journal.pone.0019799","article-title":"Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C","volume":"6","author":"K Onomoto","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"TJ Urban","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24623","article-title":"Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response","volume":"55","author":"Y Asahina","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"MT Dill","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.24056","article-title":"Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response","volume":"53","author":"JM Darling","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-022X(92)90014-2","article-title":"A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested","volume":"25","author":"DK Lahiri","year":"1992","journal-title":"J Biochem Biophys Methods"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"MW Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"e13678","DOI":"10.5812\/hepatmon.13678","article-title":"Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4","volume":"13","author":"K Domagalski","year":"2013","journal-title":"Hepat Mon"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/hepr.12070","article-title":"Hepatic interferon-gamma-induced protein-10 expression is more strongly associated with liver fibrosis than interleukin-28B single nucleotide polymorphisms in hepatocellular carcinoma resected patients with chronic hepatitis C","volume":"43","author":"H Konishi","year":"2013","journal-title":"Hepatol Res"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"AI Romero","year":"2006","journal-title":"J Infect Dis"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"JJ Feld","year":"2007","journal-title":"Hepatology"},{"issue":"19","key":"ref26","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"M Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gut.2005.074062","article-title":"Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C","volume":"55","author":"M Diago","year":"2006","journal-title":"Gut"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.23509","article-title":"Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C","volume":"51","author":"G Askarieh","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.25647","article-title":"Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response","volume":"56","author":"S Naggie","year":"2012","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-10-25","article-title":"The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin","volume":"10","author":"ZM Younossi","year":"2012","journal-title":"J Transl Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T05:29:55Z","timestamp":1540013395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130899"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130899","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725590341.793507856","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}